Spotlight on grazoprevir—elbasvir once-daily combination and its potential in the treatment of hepatitis C
Duminda Suraweera,1 Ashley N Weeratunga,2 Sammy Saab3 1Department of Medicine, Olive-View Medical Center, Sylmar, CA, 2Department of Medicine, Creighton University School of Medicine, Omaha, NE, 3Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA Abstract: Chroni...
Main Authors: | Suraweera D, Weeratunga AN, Saab S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/spotlight-on-grazoprevirmdashelbasvir-once-daily-combination-and-its-p-peer-reviewed-article-DDDT |
Similar Items
-
Elbasvir/Grazoprevir, an Alternative in Antiviral Hepatitis C Therapy in Patients under Amiodarone Treatment
by: Lina Weiss, et al.
Published: (2018-02-01) -
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
by: Youn Jae Lee, et al.
Published: (2019-12-01) -
Effectiveness and safety of elbasvir/grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
by: Eun Sun Jang, et al.
Published: (2021-03-01) -
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir
by: Ng X, et al.
Published: (2018-12-01) -
Limited drug–drug interaction of elbasvir/grazoprevir for chronic hepatitis C
by: Chun-Jen Liu, et al.
Published: (2020-05-01)